JIP
IRWD icon

Jaffetilchin Investment Partners’s Ironwood Pharmaceuticals IRWD Stock Holding History

Jaffetilchin Investment Partners’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13,613
Closed -$160K – 332
2022
Q1 		$160K Buy
+13,613
New +$156K 0.02% 306

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Jaffetilchin Investment Partners's IRWD Position: Q2 2022 in Review

Jaffetilchin Investment Partners sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2022, closing a stake of 13,613 shares — an estimated $160K sold.

Jaffetilchin Investment Partners first reported a position in IRWD in Q1 2022 and held it in 1 quarter. The position peaked at $160K in Q1 2022. 239 funds tracked by Wall St. Rank hold IRWD as of Q2 2022.

  • Jaffetilchin Investment Partners reported no remaining Ironwood Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Jaffetilchin Investment Partners sold 13,613 Ironwood Pharmaceuticals shares in Q2 2022, an estimated $160K.
  • Jaffetilchin Investment Partners first reported a position in Ironwood Pharmaceuticals in Q1 2022 and held it in 1 quarter.
  • Jaffetilchin Investment Partners's Ironwood Pharmaceuticals position peaked at $160K in Q1 2022.
  • 239 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2022.

Based on Jaffetilchin Investment Partners's 13F filing for Q2 2022, filed 15 Aug 2022.